Patrick Campbell is the senior editor of Endocrinology Network, as well as its sister publication Practical Cardiology. Prior to joining these brands, he led coverage of cardiology and diabetes with HCPLive. Before joining parent company MJH Life Sciences in 2019, he spent time as a beat reporter with the Pocono Record in Stroudsburg, PA and Star News Group in Manasquan, NJ. He also touts experience in multimedia, having spent time as a freelance multimedia specialist with NJ Advance Media and multimedia coordinator at the Pocono Record. In his free time, he enjoys traveling, sports, and exploring the great outdoors. Follow him on Twitter @RealPatCampbell or reach him via email at PCampbell@mjhlifesciences.com.

Podcasts

Check out the Endocrine Outlook podcast, brought to you by the Endocrinology Network. This episode focuses on semaglutide 1 mg as a weight loss therapy for patients who are obese or overweight. 

Subcutaneous Semaglutide as a Weight Loss Agent with Thomas Wadden, PhD

Tirzepatide for Weight Loss, Lowering HbA1c in Diabetes with Juan Frias, MD

This episode of the Endocrine Outlook podcast features an interview on dietary interventions and the role of nutrition in obesity management with Ariana Chao, PhD, CRNP, of the University of Pennsylvania. 

Dietary Interventions and the Role of Nutrition in Obesity with Ariana Chao, PhD, CRNP

Dr. Jeffrey Curtis discusses osteoporosis data presented at ACR Convergence and the current state of osteoporosis management in 2020 in the latest edition of the Endocrine Outlook podcast. 

Jeffrey Curtis, MD: Osteoporosis in 2020

Georgiana Dobri, MD, a neuroendocrinologist from Weill Cornell Medicine, discusses the approval of osilodrostat and management of Cushing's disease in 2020.

 Osilodrostat and Treatment of Cushing's Disease

A podcast episode featuring a discussion related to racial and ethnic disparities in the care of children with type 1 diabetes.

Addressing Racial Disparities in the Care of Children with Diabetes

Raymond Douglas, MD, PhD, discusses trends in treatment of thyroid eye disease and how the approval of teprotumumab has impacted the prospect of treating the condition. 

Raymond Douglas, MD, PhD: Treatment of Thyroid Eye Disease in 2020

This episode of the Endocrine Outlook podcast features a discussion around the cardiorenal benefits of SGLT2 inhibitors and GLP-1 receptor agonists.

The Endocrine Outlook: Cardiorenal Benefits of SGLT2 Inhibitors and GLP-1 Receptor Agonists

A podcast featuring the presenter of DAPA-CKD discussing results of the trial and how they inform use of dapagliflozin in patients with chronic kidney disease with and without type 2 diabetes.

Prof. Heerspink: DAPA-CKD and Use of Dapagliflozin

A podcast featuring the lead investigator of a recent study examining impact of metabolic syndrome on COVID-19 outcomes in a pair of New Orleans-based hospitals. 